Certified by Founder Lodge
Rampart Bioscience
United States - Delhi, California
START UP
1 Disclosed Funding Rounds $85,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Rampart Bioscience is evolving a new class of medicines for patients with genetically driven diseases. We integrate capabilities from a variety of key scientific disciplines — including gene
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| October, 25 ,2023 | Series A | $85,000,000 |
OrbiMed
RA Capital Management, L.P.
HealthCap
Forbion
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
